Resources
Patient Assistance Program
- Earn an annual gross income of 250% of the Federal Poverty Level (FPL) or less. If the annual gross income exceeds 250% of FPL, PAP denial will be issued
- Patients must be uninsured in order to be eligible for product assistance
- Documentation of proof of income
- Diagnosis and dosing must be consistent with FDA-approved label
- Must be a US citizen or resident and must physically reside in the US or US territory, Puerto Rico, or other US territories
- Under the care of a US licensed prescriber with an established practice located in the US
- Documentation of proof of residency will not routinely be required but may be requested at any time by the program through an audit (eg, copy of current valid driver's license or recent utility bill)
- Patient will receive 1 dose as prescribed
-
Federally funded patients are not eligible to receive assistance through the PAP. This includes but it not limited to Medicare, Medicaid (including spend downs), Tricare, and VA benefits
Frequently Asked Questions (FAQs)
Hepatitis B is liver infection caused by the hepatitis B virus (HBV). For some, HBV can cause sickness that lasts for a few weeks (known as "acute" infection), while others may contract a lifelong, chronic illness.1
Hepatitis B can be transmitted through the blood or other bodily fluids of a contaminated person to a noncontaminated person. This happens through sexual contact with an infected person, sharing of drugs or needles, percutaneous (through the skin) exposures, tattooing and body piercing in an unsanitary environment, needlesticks or sharps if you work in a medical environment, and, if a mother is infected, she can pass HBV to her child.1
The symptoms patients may encounter if exposed to hepatitis B are fever, fatigue, nausea, loss of appetite, joint or abdominal pain, vomiting, dark urine, light-colored stool, and yellowing of the skin and whites of the eyes. About one-third to half of people with acute hepatitis B will show symptoms, but children—especially those <5 years of age—will not necessarily show any symptoms of hepatitis B.1
Hepatitis B vaccine is recommended by the CDC to prevent hepatitis B in conjunction with a hepatitis B immune globulin such as HyperHEP B.1
Hepatitis B immune globulin is a treatment that contains immediate antibodies against hepatitis B. An immune globulin works much faster than a vaccine but does not last as long. Because of the potentially life-threatening nature of hepatitis B, after exposure you may decide to give your patients a hepatitis B immune globulin shot like HyperHEP B and a vaccine to make sure they get the comprehensive care they need.2,3